These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38398708)

  • 1. Novel Magnetic Resonance Imaging Tools for Hypertrophic Cardiomyopathy Risk Stratification.
    Alajmi F; Kang M; Dundas J; Haenel A; Parker J; Blanke P; Coghlan F; Khoo JK; Bin Zaid AA; Singh A; Heydari B; Yeung D; Roston TM; Ong K; Leipsic J; Laksman Z
    Life (Basel); 2024 Jan; 14(2):. PubMed ID: 38398708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.
    Kamal MU; Riaz IB; Janardhanan R
    Cardiol J; 2016; 23(3):250-63. PubMed ID: 27064795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study.
    Rowin EJ; Maron MS; Adler A; Albano AJ; Varnava AM; Spears D; Marsy D; Heitner SB; Cohen E; Leong KMW; Winters SL; Martinez MW; Koethe BC; Rakowski H; Maron BJ
    Heart Rhythm; 2022 May; 19(5):782-789. PubMed ID: 34933112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy.
    Raiker N; Vullaganti S; Collins JD; Allen BD; Choudhury L
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1147-1156. PubMed ID: 32166506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solving the Riddle of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: The Added Role of Cardiac Magnetic Resonance.
    Stankowski K; Figliozzi S; Lisi C; Catapano F; Panico C; Cannata F; Mantovani R; Frontera A; Bragato RM; Stefanini G; Monti L; Condorelli G; Francone M
    J Cardiovasc Dev Dis; 2023 May; 10(6):. PubMed ID: 37367391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Maron MS
    J Cardiovasc Magn Reson; 2012 Feb; 14(1):13. PubMed ID: 22296938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy.
    Yu T; Cai Z; Yang Z; Lin W; Su Y; Li J; Xie S; Shen J
    Acad Radiol; 2023 Sep; 30(9):1962-1978. PubMed ID: 36604228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification in pediatric hypertrophic cardiomyopathy: Insights for bridging the evidence gap?
    Nakano SJ; Menon SC
    Prog Pediatr Cardiol; 2018 Jun; 49():31-37. PubMed ID: 31097901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study.
    Negri F; Muser D; Driussi M; Sanna GD; Masè M; Cittar M; Poli S; De Bellis A; Fabris E; Puppato M; Grigoratos C; Todiere G; Aquaro GD; Sinagra G; Imazio M
    Int J Cardiol; 2021 Dec; 345():61-67. PubMed ID: 34728259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.
    Hinojar R; Zamorano JL; Gonzalez Gómez A; Plaza Martin M; Esteban A; Rincón LM; Portugal JC; Jimenez Nácher JJ; Fernández-Golfín C
    Clin Cardiol; 2017 Oct; 40(10):853-860. PubMed ID: 28614597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy.
    Hinojar R; Zamorano JL; Fernández-Méndez M; Esteban A; Plaza-Martin M; González-Gómez A; Carbonell A; Rincón LM; Nácher JJJ; Fernández-Golfín C
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1055-1065. PubMed ID: 30706353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.
    Dohy Z; Szabo L; Toth A; Czimbalmos C; Horvath R; Horvath V; Suhai FI; Geller L; Merkely B; Vago H
    Int J Cardiovasc Imaging; 2021 Jun; 37(6):2027-2036. PubMed ID: 33555536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy.
    Cavus E; Muellerleile K; Schellert S; Schneider J; Tahir E; Chevalier C; Jahnke C; Radunski UK; Adam G; Kirchhof P; Blankenberg S; Lund GK; Avanesov M; Patten M
    Clin Res Cardiol; 2021 Nov; 110(11):1757-1769. PubMed ID: 33779809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional significance of myocardial activity at
    Zhang Y; Dong Z; Wang L; Wang YL; Chen BX; Su Y; Zhao S; Yang MF
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):110-122. PubMed ID: 37642705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance.
    Noureldin RA; Liu S; Nacif MS; Judge DP; Halushka MK; Abraham TP; Ho C; Bluemke DA
    J Cardiovasc Magn Reson; 2012 Feb; 14(1):17. PubMed ID: 22348519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term risk of sudden cardiac death in hypertrophic cardiomyopathy: a cardiac magnetic resonance outcome study.
    Greulich S; Seitz A; Herter D; Günther F; Probst S; Bekeredjian R; Gawaz M; Sechtem U; Mahrholdt H
    Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):732-741. PubMed ID: 33458753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
    Ozden O; Unlu S; Kilic DI; Sherif SA; Opan S; Kemal HS; Ozmen E; Tuner H; Bingol G; Barutcu A; Nasifov M; Bakan S; Goktekin O
    Kardiologiia; 2023 Feb; 63(2):52-58. PubMed ID: 36880144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy.
    Gommans DHF; Cramer GE; Bakker J; Dieker HJ; Michels M; Fouraux MA; Marcelis CLM; Verheugt FWA; Timmermans J; Brouwer MA; Kofflard MJM
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):113-120. PubMed ID: 29063221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy.
    Rowin EJ; Maron MS
    Arrhythm Electrophysiol Rev; 2016; 5(3):197-202. PubMed ID: 28116085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.